Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Finke, Jürgen  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Radujkovic, A., Dietrich, S., Blok, H.-J., Nagler, A., Ayuk, F., Finke, J., Tischer, J., Mayer, J., Koc, Y., Sorà, F., et al. (2019). Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016). Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med374, 43-53.
B
Zeiser, R., Beelen, D.W., Bethge, W., Bornhäuser, M., Bug, G., Burchert, A., Christopeit, M., Duyster, J., Finke, J., Gerbitz, A., et al. (2019). Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
C
Shimoni, A., Labopin, M., Savani, B., Byrne, M., Volin, L., Finke, J., Niederwieser, D., Ehninger, G., Blaise, D., Beelen, D., et al. (2019). Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT.Biol Blood Marrow Transplant.
Lee, C.J., Labopin, M., Beelen, D., Finke, J., Blaise, D., Ganser, A., Itälä-Remes, M., Chevallier, P., Labussière-Wallet, H., Maertens, J., et al. (2018). Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT.Am J Hematol.
Brand, R., Putter, H., van Biezen, A., Niederwieser, D., Martino, R., Mufti, G., Onida, F., Symeonidis, A., Schmid, C., Garderet, L., et al. (2013). Comparison of Allogeneic Stem Cell Transplantation and Non-Transplant Approaches in Elderly Patients with Advanced Myelodysplastic Syndrome: Optimal Statistical Approaches and a Critical Appraisal of Clinical Results Using Non-Randomized Data.Plos One8, e74368.
D
Sommer, S., Cruijsen, M., Claus, R., Bertz, H., Wäsch, R., Marks, R., Zeiser, R., Bogatyreva, L., Blijlevens, N.M.A., May, A., et al. (2018). Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation.Leuk Res72, 20-26.
Waterhouse, M., Pfeifer, D., Duque-Afonso, J., Follo, M., Duyster, J., Depner, M., Bertz, H., and Finke, J. (2018). Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation.Clin Chem Lab Med.
E
Chalandon, Y., Passweg, J.R., Guglielmi, C., Iacobelli, S., Apperley, J., Schaap, N.P.M., Finke, J., Robin, M., Fedele, R., Bron, D., et al. (2014). Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.Haematologica.
G
Mathew, N.R., Vinnakota, J.M., Apostolova, P., Erny, D., Hamarsheh, S.'a, Andrieux, G., Kim, J.-S., Hanke, K., Goldmann, T., Chappell-Maor, L., et al. (2019). Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia.J Clin Invest.
H
Robin, M., Porcher, R., Ruggeri, A., Blaise, D., Wolschke, C., Koster, L., Angelucci, E., Stölzel, F., Potter, V., Yakoub-Agha, I., et al. (2018). HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis.Biol Blood Marrow Transplant.
I
Duque-Afonso, J., Ihorst, G., Waterhouse, M., Zeiser, R., Wäsch, R., Bertz, H., Müller-Quernheim, J., Finke, J., Marks, R., and Prasse, A. (2018). Impact of lung function on bronchiolitis obliterans syndrome and outcome after allogeneic hematopoietic cell transplantation with reduced intensity conditioning.Biol Blood Marrow Transplant.
O
Ringdén, O., Boumendil, A., Labopin, M., Canaani, J., Beelen, D., Ehninger, G., Niederwieser, D., Finke, J., Stelljes, M., Gerbitz, A., et al. (2019). OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.Biol Blood Marrow Transplant.
S
Nagler, A., Labopin, M., Dholaria, B., Finke, J., Brecht, A., Schanz, U., Niittyvuopio, R., Neubauer, A., Bornhäuser, M., Santarone, S., et al. (2019). Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.Br J Haematol.
Christopeit, M., Kuss, O., Finke, J., Bacher, U., Beelen, D.Wilhelm, Bornhäuser, M., Schwerdtfeger, R., Bethge, W.Andreas, Basara, N., Gramatzki, M., et al. (2013). Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change.J Clin Oncol.
T
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.
U
Ruggeri, A., Battipaglia, G., Labopin, M., Ehninger, G., Beelen, D., Tischer, J., Ganser, A., Schwerdtfeger, R., Glass, B., Finke, J., et al. (2016). Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.J Hematol Oncol9, 89.